Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip W Gold

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2005
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implicationsSalvatore Alesci, Pedro E Martinez, Sujata Kelkar, et al.
Molecular Psychiatry|November 17, 2019
The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune responseBashkim Kadriu, Cristan A Farmer, Peixiong Yuan, et al.
Bioorganic & Medicinal Chemistry|December 12, 2001
CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonistsLing-Wei Hsin, Xinrong Tian, Elizabeth L Webster, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans?Ilia J Elenkov, Richard Kvetnansky, Akira Hashiramoto, et al.
Archives of Internal Medicine|November 28, 2007
Low bone mass in premenopausal women with depressionFarideh Eskandari, Pedro E Martinez, Sara Torvik, et al.
Toxicology|April 22, 2008
Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonistThomas L Horn, J Brooks Harder, William D Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2005
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholiaPhilip W Gold, Ma-Li Wong, David S Goldstein, et al.
Biological Psychiatry|August 9, 2005
Mood disorders in the medically ill: scientific review and recommendationsDwight L Evans, Dennis S Charney, Lydia Lewis, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2005
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implicationsSalvatore Alesci, Pedro E Martinez, Sujata Kelkar, et al.
Molecular Psychiatry|November 17, 2019
The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune responseBashkim Kadriu, Cristan A Farmer, Peixiong Yuan, et al.
Bioorganic & Medicinal Chemistry|December 12, 2001
CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonistsLing-Wei Hsin, Xinrong Tian, Elizabeth L Webster, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans?Ilia J Elenkov, Richard Kvetnansky, Akira Hashiramoto, et al.
Archives of Internal Medicine|November 28, 2007
Low bone mass in premenopausal women with depressionFarideh Eskandari, Pedro E Martinez, Sara Torvik, et al.
Toxicology|April 22, 2008
Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonistThomas L Horn, J Brooks Harder, William D Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2005
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholiaPhilip W Gold, Ma-Li Wong, David S Goldstein, et al.
Biological Psychiatry|August 9, 2005
Mood disorders in the medically ill: scientific review and recommendationsDwight L Evans, Dennis S Charney, Lydia Lewis, et al.
Pageof 5